Canadian Imperial Venture Corp. announced that Ikänik Farms, Inc. has signed a collaborative agreement with CAS Biotechnology for cannabis research on the potential medical benefits in the treatment of COVID19 with pharmaceutical grade cannabis oil provided by Pideka's GACP and GMPPharma certified Casa Flores facility located outside of Bogota, Colombia. Pideka's cannabis is supported by agronomically certified genetics and is currently sold in Colombia for use in Formula Magistral. The testing will be conducted by CAS Biotechnology's scientific team at their research facility in Mexico. CAS Biotechnology's team is comprised of scientists with expertise in molecular and synthetic biology, bioinformatics, genomics, proteomics and preclinical trials. Pideka will provide samples to CAS Biotechnology for conducting scientific research and preclinical trials to determine the effect of cannabis oil on SARSCoV2's replication cycle.